These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19224586)

  • 1. Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndrome.
    Rouleau E; Lefol C; Bourdon V; Coulet F; Noguchi T; Soubrier F; Bièche I; Olschwang S; Sobol H; Lidereau R
    Hum Mutat; 2009 Jun; 30(6):867-75. PubMed ID: 19224586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution melting analyses for gene scanning of APC, MLH1, MSH2, and MSH6 associated with hereditary colorectal cancer.
    Obul J; Itoga S; Abliz M; Sato K; Ishige T; Utsuno E; Matsushita K; Matsubara H; Nomura F
    Genet Test Mol Biomarkers; 2012 May; 16(5):406-11. PubMed ID: 22283331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.
    Coulet F; Pires F; Rouleau E; Lefol C; Martin S; Colas C; Cohen-Haguenauer O; Giurgea I; Fajac A; Noguès C; Demange L; Hardouin A; Lidereau R; Soubrier F
    Genet Test Mol Biomarkers; 2010 Oct; 14(5):677-90. PubMed ID: 20858050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR.
    Perez-Cabornero L; Velasco E; Infante M; Sanz D; Lastra E; Hernández L; Miner C; Duran M
    Eur J Cancer; 2009 May; 45(8):1485-93. PubMed ID: 19250818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a quantitative PCR-high-resolution melting protocol for simultaneous screening of COL1A1 and COL1A2 point mutations and large rearrangements: application for diagnosis of osteogenesis imperfecta.
    Gentile FV; Zuntini M; Parra A; Battistelli L; Pandolfi M; Pals G; Sangiorgi L
    Hum Mutat; 2012 Dec; 33(12):1697-707. PubMed ID: 22753364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements.
    De Lellis L; Curia MC; Catalano T; De Toffol S; Bassi C; Mareni C; Bertario L; Battista P; Mariani-Costantini R; Radice P; Cama A
    Hum Mutat; 2006 Oct; 27(10):1047-56. PubMed ID: 16941473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques.
    Nakagawa H; Hampel H; de la Chapelle A
    Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene.
    Tang R; Hsiung C; Wang JY; Lai CH; Chien HT; Chiu LL; Liu CT; Chen HH; Wang HM; Chen SX; Hsieh LL;
    Clin Genet; 2009 Apr; 75(4):334-45. PubMed ID: 19419416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA.
    Taylor CF; Charlton RS; Burn J; Sheridan E; Taylor GR
    Hum Mutat; 2003 Dec; 22(6):428-33. PubMed ID: 14635101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.
    Martínez-Bouzas C; Ojembarrena E; Beristain E; Errasti J; Viguera N; Tejada Minguéz MI
    Cancer Lett; 2007 Oct; 255(2):295-9. PubMed ID: 17582678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.
    Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T
    Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH).
    Staaf J; Törngren T; Rambech E; Johansson U; Persson C; Sellberg G; Tellhed L; Nilbert M; Borg A
    Hum Mutat; 2008 Apr; 29(4):555-64. PubMed ID: 18330910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.
    Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study).
    Kurzawski G; Suchy J; Lener M; Kłujszo-Grabowska E; Kładny J; Safranow K; Jakubowska K; Jakubowska A; Huzarski T; Byrski T; Debniak T; Cybulski C; Gronwald J; Oszurek O; Oszutowska D; Kowalska E; Góźdź S; Niepsuj S; Słomski R; Pławski A; Łacka-Wojciechowska A; Rozmiarek A; Fiszer-Maliszewska Ł; Bebenek M; Sorokin D; Sasiadek MM; Stembalska A; Grzebieniak Z; Kilar E; Stawicka M; Godlewski D; Richter P; Brozek I; Wysocka B; Limon J; Jawień A; Banaszkiewicz Z; Janiszewska H; Kowalczyk J; Czudowska D; Scott RJ; Lubiński J
    Clin Genet; 2006 Jan; 69(1):40-7. PubMed ID: 16451135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome.
    Morak M; Koehler U; Schackert HK; Steinke V; Royer-Pokora B; Schulmann K; Kloor M; Höchter W; Weingart J; Keiling C; Massdorf T; Holinski-Feder E;
    J Med Genet; 2011 Aug; 48(8):513-9. PubMed ID: 21712435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction.
    Vaughn CP; Lyon E; Samowitz WS
    J Mol Diagn; 2008 Jul; 10(4):355-60. PubMed ID: 18556772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
    Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
    Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
    Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2.
    Holinski-Feder E; Müller-Koch Y; Friedl W; Moeslein G; Keller G; Plaschke J; Ballhausen W; Gross M; Baldwin-Jedele K; Jungck M; Mangold E; Vogelsang H; Schackert HK; Lohsea P; Murken J; Meitinger T
    J Biochem Biophys Methods; 2001 Jan; 47(1-2):21-32. PubMed ID: 11179758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.